Early treatment with Copaxone ‘benefits patients’
Early treatment with Copaxone ‘benefits patients’
Teva has announced new data on the safety and efficacy of Copaxone (glatiramer acetate injection) 40mg/mL in patients with relapsing forms of multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1715 Views
-
Last post by NHE
-
- 0 Replies
- 1300 Views
-
Last post by frodo
-
- 0 Replies
- 1368 Views
-
Last post by frodo
-
- 0 Replies
- 2018 Views
-
Last post by DIM
-
- 0 Replies
- 1545 Views
-
Last post by frodo
-
- 0 Replies
- 1549 Views
-
Last post by NHE
-
- 0 Replies
- 2465 Views
-
Last post by frodo
-
- 5 Replies
- 14708 Views
-
Last post by gibbledygook
-
- 5 Replies
- 2508 Views
-
Last post by Jaded